Clinical Efficacy and Safety of Aidi Injection Plus Docetaxel-Based Chemotherapy in Advanced Nonsmall Cell Lung Cancer: A Meta-Analysis of 36 Randomized Controlled Trials

Background. Aidi injection is an important adjuvant anticancer drug commonly used in China. Can Aidi injection plus docetaxel-based chemotherapy improve clinical efficacy with good safety in NSCLC? To further reveal its clinical effectiveness, we systematically evaluated all the related studies. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Zheng, Wang, Chengqiong, Li, Lianhong, Tang, Xuemei, Li, Nana, Li, Jing, Chen, Ling, Gong, Qihai, Tang, Fushan, Feng, Jihong, Li, Xiaofei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016159/
https://www.ncbi.nlm.nih.gov/pubmed/29991956
http://dx.doi.org/10.1155/2018/7918258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016159/
https://www.ncbi.nlm.nih.gov/pubmed/29991956
http://dx.doi.org/10.1155/2018/7918258

Ejemplares similares